Cargando…
Adaptive design clinical trials: Methodology, challenges and prospect
New drug development is a time-consuming and expensive process. Recently, there has been stagnation in the development of novel compounds. Moreover, the attrition rate in clinical research is also on the rise. Fearing more stagnation, the Food and Drug Administration released the critical path initi...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941608/ https://www.ncbi.nlm.nih.gov/pubmed/20927243 http://dx.doi.org/10.4103/0253-7613.68417 |